108 Volunteers Sign up for Stage 1 COVID-19 Vaccine Trials in Wuhan Held by CanSino Bio-B


Stage 1 clinical testing of a COVID-19 vaccine has officially commenced in the Hubei province capital of Wuhan where the disease first broke out.

According to a report from Science and Technology Daily a total of 108 volunteers are participating in stage 1 testing, all of whom are permanent residents of the Wuhan area.

Participants received injections of the vaccine during the period from 18 – 20 March, before submitting to a 14 day quarantine and observation period.

The Academy of Military Medical Sciences and Hong Kong-listed CanSino Bio-B are responsible for holding the trials, according to information from the Chinese Clinical Trial Registry.

The stage 1 test participants are divided into three groups – a low dose group, a medium dose group and a high dose group. Each group is comprised of 36 volunteers.

According to Science and Technology Daily the vaccine was developed via genetic engineering, using replication-defective human type 5 adenovirus as a vector and expressing the new coronavirus S antigen.

Related stories

COVID-19 Vac­cine Test­ing Com­mences in Wuhan

19 Chi­nese Drug Com­pa­nies Work­ing on Novel Coro­n­avirus Vac­cine

Coro­n­avirus Vac­cines En­ter An­i­mal Test­ing Phase: Chi­na’s Sci­ence Min­istry